Prostatype Genomics AB banner
P

Prostatype Genomics AB
OTC:PGABF

Watchlist Manager
Prostatype Genomics AB
OTC:PGABF
Watchlist
Price: 0.3584 -10.4% Market Closed
Market Cap: 1.8m

Intrinsic Value

The intrinsic value for Prostatype Genomics AB (PGABF) under the Base Case is hidden . Compared with the current market price of 0.3584 , the stock appears hidden .

Intrinsic value calculated using Multiples
Locked

Do our valuations actually work? See backtest results .

PGABF Intrinsic Value
LOCKED
Unlock

Valuation context is not available yet

There is not enough comparable price and intrinsic value history for PGABF.

Monitor PGABF
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price 0.36
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about PGABF?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PGABF valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Prostatype Genomics AB.

Explain Valuation
Alternatives to PGABF

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
Prostatype Genomics AB

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one PGABF stock?

The intrinsic value for Prostatype Genomics AB (PGABF) under the Base Case is hidden .

Is PGABF stock undervalued or overvalued?

Compared with the current market price of 0.3584 , the stock appears hidden.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett